Keyphrases
S-phase Kinase-associated Protein 2 (Skp2)
50%
Metabolic Targets
50%
Castration-resistant Prostate Cancer
50%
Nitazoxanide
50%
Novel Therapies
50%
Prostate Cancer
42%
Cancer Activity
42%
Prostate Cancer Cells
28%
Male Hormones
21%
Resistant Prostate Cancer
21%
Hormone Therapy
21%
Anti-prostate Cancer
21%
Therapy-resistant
21%
Antiparasitic Drugs
14%
Safety Profile
14%
Anticipated Outcomes
14%
Generative Process
14%
Resume
7%
Critical Energy
7%
Therapy Resistance
7%
Approved Drugs
7%
Chemical Compounds
7%
Therapy Treatment
7%
Cell Culture
7%
Hormone Production
7%
Drug Screening
7%
Deprivation
7%
Clinical Testing
7%
Skin Cancer
7%
Patient Survival
7%
Metastasis
7%
Mouse Model
7%
Rapid Development
7%
Selling
7%
Patients with Cancer
7%
United States
7%
Enzalutamide
7%
Cancer Mortality
7%
Diarrhea
7%
Treatment Options
7%
Culture in Vitro
7%
Molecular Mechanism
7%
Androgen Receptor
7%
Prostate Cancer Patients
7%
Hormone Receptor
7%
Clinically Significant
7%
Cancer Causes
7%
Medicine and Dentistry
Castration Resistant Prostate Cancer
100%
Prostate Cancer
100%
Nitazoxanide
50%
Cancer Cell
25%
Hormone Therapy
18%
Antiparasitic Agent
12%
Disease
12%
Therapy Resistance
6%
Skin Cancer
6%
Cancer Mortality
6%
In Vitro
6%
Hormone Receptor
6%
Parasite (Microbiology)
6%
Androgen Receptor
6%
Hormone Synthesis
6%
Metastatic Carcinoma
6%
Enzalutamide
6%
Diarrhea
6%
Drug Screening
6%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Castration Resistant Prostate Cancer
100%
Nitazoxanide
50%
Endocrine Therapy
18%
Antiparasitic Agent
12%
Disease
12%
Drug Screening
6%
Hormone Receptor
6%
Diarrhea
6%
Skin Cancer
6%
Disseminated Cancer
6%
Mouse Model
6%
Therapy Resistance
6%
Cancer Mortality
6%
Enzalutamide
6%
Androgen Receptor
6%